NasdaqGM - Delayed Quote USD
Neurogene Inc. (NGNE)
At close: October 21 at 4:00 PM EDT
After hours: October 21 at 6:03 PM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 1.39M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
CVIJIC CHRISTINE MIKAIL President | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 13, 2024 |
COBB STUART Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 13, 2024 |
BAKER BROS ADVISORS L.P. Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Oct 5, 2023 |
BAKER BROS ADVISORS L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 0.63 - 0.69 per share. | Indirect | 1,463,487 | Aug 17, 2023 |
SMITH SEAN MICHAEL Chief Financial Officer | Sale at price 0.62 per share. | Direct | 818 | Aug 11, 2023 |
SMITH SEAN MICHAEL Chief Financial Officer | -- | Direct | -- | Aug 10, 2023 |
PATEL PRITI Former | Sale at price 0.69 per share. | Direct | 2,608 | Apr 3, 2023 |
PATEL PRITI Former | -- | Direct | -- | Mar 31, 2023 |
PATEL PRITI Officer | Sale at price 0.60 per share. | Direct | 8,588 | Feb 2, 2023 |
SMITH SEAN MICHAEL Officer | Sale at price 0.60 per share. | Direct | 1,980 | Feb 2, 2023 |
PATEL PRITI Officer | -- | Direct | -- | Feb 1, 2023 |
SMITH SEAN MICHAEL Officer | -- | Direct | -- | Feb 1, 2023 |
Related Tickers
LXEO Lexeo Therapeutics, Inc.
10.52
-5.40%
SYRE Spyre Therapeutics, Inc.
32.43
-1.01%
LYEL Lyell Immunopharma, Inc.
1.1200
-4.27%
TSHA Taysha Gene Therapies, Inc.
2.0200
-1.94%
CRGX CARGO Therapeutics, Inc.
20.96
-5.67%
IRON Disc Medicine, Inc.
50.77
+0.42%
TRML Tourmaline Bio, Inc.
28.31
+0.16%
DNTH Dianthus Therapeutics, Inc.
28.38
-2.31%
PTCT PTC Therapeutics, Inc.
38.44
-1.69%
ASND Ascendis Pharma A/S
128.66
-0.95%